2013
Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa
Lygizos M, Shenoi SV, Brooks RP, Bhushan A, Brust J, Zelterman D, Deng Y, Northrup V, Moll AP, Friedland GH. Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa. BMC Infectious Diseases 2013, 13: 300. PMID: 23815441, PMCID: PMC3716713, DOI: 10.1186/1471-2334-13-300.Peer-Reviewed Original ResearchConceptsTB transmission riskInfectious TB patientsTransmission riskTB patientsRural South AfricaDrug-resistant TBTB control effortsHealth care facilitiesPaucity of dataHousehold settingsRural KwaZulu-NatalPrevalent TBResistant TBTB transmissionCare facilitiesMultivariate analysisHIV areasVentilationAChSignificant decreaseWells-Riley equationPatientsRiskLow ventilationHour period
2010
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis
Karim Q, Karim S, Baxter C, Friedland G, Gengiah T, Gray A, Grobler A, Naidoo K, Padayatchi N, El-Sadr W. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. South African Medical Journal 2010, 100: 808-809. PMID: 21414268, DOI: 10.7196/samj.4621.Peer-Reviewed Original Research
2008
Episodic Antiretroviral Therapy Increases HIV Transmission Risk Compared With Continuous Therapy: Results of a Randomized Controlled Trial
Burman W, Grund B, Neuhaus J, Douglas J, Friedland G, Telzak E, Colebunders R, Paton N, Fisher M, Rietmeijer C. Episodic Antiretroviral Therapy Increases HIV Transmission Risk Compared With Continuous Therapy: Results of a Randomized Controlled Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2008, 49: 142-150. PMID: 18769356, PMCID: PMC2749067, DOI: 10.1097/qai.0b013e318183a9ad.Peer-Reviewed Original ResearchConceptsHIV transmission riskHigh-risk behaviorsEpisodic antiretroviral therapyAntiretroviral therapyTransmission riskContinuous antiretroviral therapyHIV RNA levelsAntiretroviral Therapy studyProportion of participantsTherapy armContinuous therapyControlled TrialsRandomized armHIV transmissionMean ageNeedle sharingPatientsTherapyTherapy studiesStrategy of managementRNA levelsSexual activityRiskBaselineLaboratory testing
1989
Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus.
Schrager L, Friedland G, Maude D, Schreiber K, Adachi A, Pizzuti D, Koss L, Klein R. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 570-5. PMID: 2555473.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHuman papillomavirus infectionPapillomavirus infectionImmunodeficiency virusLower genital tract neoplasiaGenital HPV infectionGenital tract neoplasiaSquamous cell abnormalitiesHPV infectionSquamous abnormalitiesHIV infectionHigh prevalenceCytological abnormalitiesNeoplastic disordersCervicovaginal smearsHigh riskCell abnormalitiesBlinded fashionInfectionWomenAbnormalitiesCellular changesFurther studiesVirusRisk